Get the Stockscreener App
6.95
0.71%
-0.05
Neonc Technologies Holdings Inc stock is traded at $6.95, with a volume of 20,391.
It is down -0.71% in the last 24 hours and up +0.00% over the past month.
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").
See More
Previous Close:
$7.00
Open:
$7
24h Volume:
20,391
Relative Volume:
1.45
Market Cap:
$149.03M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-22.78%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$6.61
$7.00
1-Week Range:
$6.61
$10.30
52-Week Range:
$6.10
$21.00
Neonc Technologies Holdings Inc Stock (NTHI) Company Profile
Name
Neonc Technologies Holdings Inc
Sector
Industry
Phone
-
Address
-
Compare NTHI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTHI
Neonc Technologies Holdings Inc
|
6.95 | 149.03M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Neonc Technologies Holdings Inc Stock (NTHI) Latest News
NeOnc Technologies Appoints New President Amid Strategic Moves - MSN
NeOnc Technologies announces global patent portfolio totals 176 - TipRanks
NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets - GlobeNewswire
NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical - Bluefield Daily Telegraph
NeOnc Sees Share Price Fall Since Going Public - Los Angeles Business Journal
NeOnc Technologies expects full enrollment in Phase 2a trial of NEO100-01 - TipRanks
NeOnc Technologies Expects Full Enrollment in Phase 2a Trialfor NEO100-01 by September - marketscreener.com
Neonc Technologies Holdings Expects Full Enrollment In Promising Phase 2A Trial Of Neo100-01 For Malignant Gliomas In September - MarketScreener
NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September - The Manila Times
Planet TV Studios Airing “New Frontiers” Episode on NeOnc Technologies Holdings, Inc. – Saturday, April 12th, - EIN News
New CEOs at Alterome, Valo and Imbria - BioCentury
NeOnc Technologies Appoints Executive Chairman Amir Heshmatpour as President - MarketScreener
NeOnc Technologies Holdings, Inc. Executive Chairman, Amir - GlobeNewswire
Germany's economy is expected to stagnate at best this year - The Globe and Mail
2 Reasons Nu Holdings Stock Is a Buy Before May 13 - The Globe and Mail
Rigetti Computing Stock (RGTI) Surges 21% as Market Optimism Returns - The Globe and Mail
NeOnc Technologies Phase 1 Trial Enrollment for NEO212 Brain Cancer Drug Nears Full Enrollment - MarketScreener
NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy - GlobeNewswire
Dow Jones Index Daily Report: DIA Rebounds Today After Tariff Tantrum - The Globe and Mail
Nvidia Stock (NVDA) Smashes Back as AI Demand Counters Tariff Panic - The Globe and Mail
NeOnc Technologies Partners with CBCC for Clinical Expansion - TipRanks
Neonc Technologies appoints new accounting firm By Investing.com - Investing.com Canada
Neonc Technologies appoints new accounting firm - Investing.com India
NeOnc Technologies receives RPDD for NEO100 - TipRanks
NeOnc Technologies Holdings: New IPO gets a Rare Pediatric Disease Designation and a 37.92% Jump in the Market - RagingBull
NeOnc Technologies Holdings' Perillyl Alcohol Receives FDA's Rare Pediatric Disease Designation - MarketScreener
NeOnc Falls Despite FDA Nod - Baystreet.ca
NeOnc Technologies Holdings, Inc. Receives Rare Pediatric - GlobeNewswire
Robinhood, Couchbase And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas - Yahoo Finance
NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments - The Manila Times
NeOnc Technologies Expands Global Clinical Trial Network - GlobeNewswire
NeOnc Technologies Holdings, Inc. Rings the Opening Bell - Nasdaq
NTHI IPO NewsBiotech NeOnc Technologies' share registration declared effective ahead of Nasdaq direct listing - renaissancecapital.com
NeOnc Technologies Holdings Announces Effectiveness of - GlobeNewswire
NeOnc Technologies Holdings Announces Effectiveness of Registration Statement and Anticipated Listing Date of Common Stock on Nasdaq Global Market - Yahoo Finance
NEONC Technologies Holdings, Inc. Appoints Dr. Alan Chiang to its Board of Directors - Yahoo Finance
NeOnc Technologies Appointments the Honorable Jimmy Delshad to its Board of Directors - GlobeNewswire
NeOnc Technologies Holdings, Inc. Appoints Bader Almonawer to Board of Directors - GlobeNewswire
NEONC Technologies Holdings, Inc. Appoints Renowned Neurosurgeon Dr. Steven L. Giannotta to its Board of Directors - The Manila Times
NeOnc Technologies Holdings, Inc. Appoints Dr. Steven L. Giannotta to Board of Directors - Nasdaq
Nasdaq’s opening bell will ring for USC research startup NeOnc - USC Today
Q4 Gas and Liquid Handling Earnings: SPX Technologies (NYSE:SPXC) Impresses - The Globe and Mail
Planet TV Studios Airing “New Frontiers” Episode on NeOnc Technologies Holdings, Inc. – Saturday, March 15, - EIN News
Expanding horizons: NeOnc Technologies’ bold vision - The Business Journals
NeOnc Technologies plans to go public through direct listing - AlphaStreet
NeOnc Technologies has another go at a Nasdaq listing - pharmaphorum
NeOnc files for direct listing in wake of pulled IPO (NTHI:NASDAQ) - Seeking Alpha
NeOnc Technologies Receives Pharma Tech Outlook’s Top Drug Delivery Platform Award for 2024 - GlobeNewswire
A Biotech Going Through the Nose to Treat the Brain Plots Alternative Path to Public Markets - MedCity News
NeOnc Technologies Begins Enrollment for Phase 2 Clinical - GlobeNewswire
Neonc Technologies Holdings Inc Stock (NTHI) Financials Data
There is no financial data for Neonc Technologies Holdings Inc (NTHI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):